A first-in-human study evaluating safety, PK, and PD of a novel universal anticoagulant reversal agent, OKL-1111.
- DOI
- 10.1016/j.bvth.2026.100176
- Published
- 2026 Aug
- Container
- Blood vessels, thrombosis & hemostasis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bvth.2026.100176,
title = {A first-in-human study evaluating safety, PK, and PD of a novel universal anticoagulant reversal agent, OKL-1111.},
author = {Spaans E and Wilkes D and Schreurs M and Beyrath J and Heuberger JAAC and Zwiers A and Patel H and Bakhtiari K and Meijers JCM and Peters SLM},
year = {2026},
journal = {Blood vessels, thrombosis \& hemostasis},
doi = {10.1016/j.bvth.2026.100176},
url = {https://doi.org/10.1016/j.bvth.2026.100176}
}RIS
TY - JOUR TI - A first-in-human study evaluating safety, PK, and PD of a novel universal anticoagulant reversal agent, OKL-1111. AU - Spaans E AU - Wilkes D AU - Schreurs M AU - Beyrath J AU - Heuberger JAAC AU - Zwiers A AU - Patel H AU - Bakhtiari K AU - Meijers JCM AU - Peters SLM PY - 2026 JO - Blood vessels, thrombosis & hemostasis DO - 10.1016/j.bvth.2026.100176 UR - https://doi.org/10.1016/j.bvth.2026.100176 ER -
APA
E, S., D, W., M, S., J, B., JAAC, H., A, Z., H, P., K, B., JCM, M., & SLM, P. (2026). A first-in-human study evaluating safety, PK, and PD of a novel universal anticoagulant reversal agent, OKL-1111.. Blood vessels, thrombosis & hemostasis. https://doi.org/10.1016/j.bvth.2026.100176
Source records
- pubmed · retrieved 2026-09-25T01:56:32.206Z